Alba Espargaró - Nanotechnology

Author Information

Alba Espargaró is a researcher affiliated with the Institute of Nanoscience and Nanotechnology (IN2UB) at the University of Barcelona in Barcelona, Catalonia, Spain. Her work primarily focuses on the fields of nanotechnology and neurodegenerative diseases, particularly Alzheimer's disease.

Research Contributions

Alba Espargaró has made significant contributions to the understanding of amyloid aggregation, oxidative stress, and neuroinflammation, which are critical factors in Alzheimer's disease. Her research includes the development of multifunctional anti-Alzheimer's agents, studying the effects of metal coordination on amyloid-β aggregation, and investigating the binding mechanisms of Congo Red to amyloid fibrils. Additionally, she has explored the design and synthesis of various inhibitors targeting amyloid-β and tau aggregation, as well as cholinesterase inhibitors.

Aliases

A Espargaro, A. Espargaró, Alba Espargaro, Alba Espargaró

Publication and Citation Metrics

Metric	Value
Citation Count	1481
H-Index	25
Paper Count	58

Publications:

Azobioisosteres of Curcumin with Pronounced Activity against Amyloid Aggregation, Intracellular Oxidative Stress, and Neuroinflammation

DOI: 10.1002/chem.202005263

Year: 2021

Dual Inhibitors of Amyloid-β and Tau Aggregation with Amyloid-β Disaggregating Properties: Extended In Cellulo, In Silico, and Kinetic Studies of Multifunctional Anti-Alzheimer’s Agents

DOI: 10.1021/acschemneuro.1c00235

Year: 2021

Dual Effect of Prussian Blue Nanoparticles on Aβ40 Aggregation: β-Sheet Fibril Reduction and Copper Dyshomeostasis Regulation.

DOI: 10.1021/acs.biomac.0c01290

Year: 2021

New Pyrimidine and Pyridine Derivatives as Multitarget Cholinesterase Inhibitors: Design, Synthesis, and In Vitro and In Cellulo Evaluation

DOI: 10.1021/acschemneuro.1c00485

Year: 2021

Thiosemicarbazone Derivatives as Inhibitors of Amyloid-β Aggregation: Effect of Metal Coordination.

DOI: 10.1021/acs.inorgchem.0c00467

Year: 2020

On the Binding of Congo Red to Amyloid Fibrils.

DOI: 10.1002/anie.201916630

Year: 2020

Pharmacophore Modeling and 3D-QSAR Study of Indole and Isatin Derivatives as Antiamyloidogenic Agents Targeting Alzheimer’s Disease †

DOI: 10.3390/molecules25235773

Year: 2020

On the Binding of Congo Red to Amyloid Fibrils

DOI: 10.1002/ange.201916630

Year: 2020

Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6.

DOI: 10.1021/acs.jmedchem.0c00528

Year: 2020

Bacterial Inclusion Bodies for Anti-Amyloid Drug Discovery: Current and Future Screening Methods.

DOI: 10.2174/1389203720666190329120007

Year: 2019

Are there any existing GitHub repositories relevant to Nanotechnology?

What are Microporous Materials?

What is Physical Adsorption?

How Does Nanotechnology Affect Employment?

What Are Some Key Components in Quantum Information Systems?

How Can Magnetic Interference be Mitigated?

How Does the Database Support Regulatory Decision Making?

What are the Applications of Nanotechnology-Enhanced Materials?

What is Electron Beam Therapy?

What Are the Implications of Threshold Voltage Roll Off?

Partnered Content Networks

Relevant Topics